Cargando…
Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy that imposes great challenges in terms of drug resistance and relapse. Previous studies revealed heterogeneous leukemia cells and their relevant gene markers, such as CRIP1 as clinically prognostic in t (8;21) AML patien...
Autores principales: | Gao, Yan, Li, Jin-Yuan, Mao, Jia-Ying, Zhou, Jia-Fan, Jiang, Lu, Li, Xue-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354089/ https://www.ncbi.nlm.nih.gov/pubmed/35938037 http://dx.doi.org/10.3389/fgene.2022.923568 |
Ejemplares similares
-
Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023) -
Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia
por: Gao, Yan, et al.
Publicado: (2022) -
Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration
por: Zheng, Guowei, et al.
Publicado: (2022) -
Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia
por: Xue, Jia, et al.
Publicado: (2023) -
TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
por: Shaikh, Abdul Rehman Khalil, et al.
Publicado: (2021)